DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding
Open Access
- 3 January 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (1) , 178-187
Abstract
The origin of aberrant DNA methylation in cancer remains largely unknown. In the present study, we elucidated the DNA methylome in primary acute promyelocytic leukemia (APL) and the role of promyelocytic leukemia–retinoic acid receptor α (PML-RARα) in establishing these patterns. Cells from APL patients showed increased genome-wide DNA methylation with higher variability than healthy CD34+ cells, promyelocytes, and remission BM cells. A core set of differentially methylated regions in APL was identified. Age at diagnosis, Sanz score, and Flt3-mutation status characterized methylation subtypes. Transcription factor–binding sites (eg, the c-myc–binding sites) were associated with low methylation. However, SUZ12- and REST-binding sites identified in embryonic stem cells were preferentially DNA hypermethylated in APL cells. Unexpectedly, PML-RARα–binding sites were also protected from aberrant DNA methylation in APL cells. Consistent with this, myeloid cells from preleukemic PML-RARα knock-in mice did not show altered DNA methylation and the expression of PML-RARα in hematopoietic progenitor cells prevented differentiation without affecting DNA methylation. Treatment of APL blasts with all-trans retinoic acid also did not result in immediate DNA methylation changes. The results of the present study suggest that aberrant DNA methylation is associated with leukemia phenotype but is not required for PML-RARα–mediated initiation of leukemogenesis. Key Points APL is characterized by DNA hypermethylation with increased variability and DNA hypomethylation at chromosome ends. Occupied transcription factor binding sites, including PML-RAR&α binding sites, are protected from DNA methylation in APL.Keywords
This publication has 51 references indexed in Scilit:
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaNature Medicine, 2012
- DNA-binding factors shape the mouse methylome at distal regulatory regionsNature, 2011
- Dnmt3a is essential for hematopoietic stem cell differentiationNature Genetics, 2011
- Comprehensive methylome map of lineage commitment from haematopoietic progenitorsNature, 2010
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid LeukemiaCancer Cell, 2010
- High-throughput bisulfite sequencing in mammalian genomesMethods, 2009
- The cancer genomeNature, 2009
- Targeted and genome-scale strategies reveal gene-body methylation signatures in human cellsNature Biotechnology, 2009
- Genome-scale DNA methylation maps of pluripotent and differentiated cellsNature, 2008
- Control of Developmental Regulators by Polycomb in Human Embryonic Stem CellsCell, 2006